Positron Emission Tomography in Merkel Cell Carcinoma.
18F-fluorodeoxyglucose (18F-FDG)
68Ga-labeled somatostatin analogues
Merkel cell carcinoma (MCC)
positron emission tomography/computed tomography (PET/CT)
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
09 Oct 2020
09 Oct 2020
Historique:
received:
03
09
2020
revised:
05
10
2020
accepted:
06
10
2020
entrez:
14
10
2020
pubmed:
15
10
2020
medline:
15
10
2020
Statut:
epublish
Résumé
Merkel cell carcinoma (MCC) is a rare neuroendocrine skin malignancy usually arising as a nonspecific nodule on sun-exposed areas of the head and neck. Given the poor prognosis of this aggressive tumor, assessment of disease burden in pre- and post-treatment care may ensure an optimal management with significant implications for patient surveillance and prognosis. Although imaging has established its role in locally advanced or distant metastatic MCC, a standard imaging algorithm is yet to be determined and respective recommendations are mainly based on melanoma. Positron emission tomography/computed tomography (PET/CT) is increasingly evolving as a valuable imaging tool in metastatic or unresectable MCC, mostly utilizing the glucose analogue
Identifiants
pubmed: 33050255
pii: cancers12102897
doi: 10.3390/cancers12102897
pmc: PMC7601068
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
BMJ Case Rep. 2019 Mar 9;12(3):
pubmed: 30852509
Clin Nucl Med. 2002 Dec;27(12):922-3
pubmed: 12607889
Br J Cancer. 2013 Dec 10;109(12):2973-9
pubmed: 24149172
Clin Nucl Med. 2012 Aug;37(8):759-62
pubmed: 22785503
Br J Dermatol. 2020 Apr 22;:
pubmed: 32320473
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1197-1198
pubmed: 30535745
Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):695-706
pubmed: 26519292
N Engl J Med. 2016 Jun 30;374(26):2542-52
pubmed: 27093365
J Nucl Med. 2005 Jan;46 Suppl 1:172S-8S
pubmed: 15653666
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):78-84
pubmed: 12483413
Ann Surg Oncol. 2016 Oct;23(11):3564-3571
pubmed: 27198511
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):943-66
pubmed: 23417499
Skeletal Radiol. 2015 Jun;44(6):777-86
pubmed: 25631356
Nucl Med Commun. 2016 Aug;37(8):865-73
pubmed: 27092665
J Nucl Med. 2013 Aug;54(8):1223-9
pubmed: 23753187
Clin Nucl Med. 2012 Nov;37(11):1108-11
pubmed: 22996252
Oncol Rep. 2006 Aug;16(2):347-52
pubmed: 16820914
Clin Nucl Med. 2013 Apr;38(4):283-4
pubmed: 23429397
Cancer Immunol Immunother. 2019 May;68(5):813-822
pubmed: 30123922
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):e389-e391
pubmed: 28256019
J Am Acad Dermatol. 2012 Dec;67(6):1250-6
pubmed: 22552001
Nucl Med Commun. 1998 Feb;19(2):97-105
pubmed: 9548192
Radiographics. 2004 Mar-Apr;24(2):523-43
pubmed: 15026598
Clin Nucl Med. 2004 Feb;29(2):86-90
pubmed: 14734903
Syst Rev. 2012 Dec 13;1:62
pubmed: 23237499
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Mol Imaging Biol. 2006 Jul-Aug;8(4):212-7
pubmed: 16724293
Clin Positron Imaging. 2000 Mar;3(2):71-73
pubmed: 10838403
J Am Acad Dermatol. 2020 Jul 21;:
pubmed: 32707254
Ann Nucl Med. 2012 May;26(4):365-9
pubmed: 22361935
BMJ Case Rep. 2010 Oct 13;2010:
pubmed: 22789832
BMC Cancer. 2014 Apr 17;14:268
pubmed: 24742330
N Engl J Med. 2009 Jul 2;361(1):32-9
pubmed: 19571281
Dermatol Clin. 2019 Jul;37(3):269-277
pubmed: 31084721
J Nucl Med. 1998 Dec;39(12):2087-90
pubmed: 9867147
Br J Dermatol. 2003 Jun;148(6):1135-40
pubmed: 12828740
Blood. 2006 Jan 1;107(1):52-9
pubmed: 16150944
J Am Acad Dermatol. 2013 Apr;68(4):592-599
pubmed: 23127473
Radiographics. 2019 Nov-Dec;39(7):2069-2084
pubmed: 31697628
Ann Oncol. 2001 Jun;12(6):807-11
pubmed: 11484956
J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1507-11
pubmed: 26446694
Mol Imaging Biol. 2005 Jul-Aug;7(4):257-61
pubmed: 16082495
Australas J Dermatol. 2017 May;58(2):99-105
pubmed: 26459330
J Nucl Med. 2001 Feb;42(2):248-56
pubmed: 11216523
Dermatol Surg. 2013 Sep;39(9):1323-33
pubmed: 23777452
J Nucl Med Technol. 2016 Jun;44(2):85-7
pubmed: 26471333
Am J Clin Dermatol. 2013 Dec;14(6):437-47
pubmed: 23959776
Ann Surg. 2011 Apr;253(4):666-71
pubmed: 21475005
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1617-26
pubmed: 17520251
J Am Acad Dermatol. 2010 Nov;63(5):751-61
pubmed: 20646783
Hematol Oncol Clin North Am. 2019 Feb;33(1):39-52
pubmed: 30497676
Eur J Cancer. 2015 Nov;51(16):2396-403
pubmed: 26257075
EJNMMI Res. 2018 Jul 21;8(1):64
pubmed: 30032450
Eur J Nucl Med. 2001 Dec;28(12):1751-7
pubmed: 11734911
J Nucl Med. 2007 Apr;48(4):508-18
pubmed: 17401086
J Med Imaging Radiat Oncol. 2018 Jun;62(3):412-419
pubmed: 29405630
Nucl Med Commun. 2014 Mar;35(3):282-90
pubmed: 24240193
Am J Clin Oncol. 2005 Apr;28(2):205-10
pubmed: 15803018
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2090-2
pubmed: 25012872
J Am Acad Dermatol. 2018 Mar;78(3):445-454
pubmed: 29229573
J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1420-7
pubmed: 21366705
South Med J. 2004 Nov;97(11):1110-2
pubmed: 15586604
Arch Dermatol. 2006 Jun;142(6):685-90
pubmed: 16785370
JAAD Case Rep. 2019 Sep 24;5(10):849-851
pubmed: 31649970
Cancer Immunol Res. 2015 Oct;3(10):1185-92
pubmed: 26100356
J Immunother Cancer. 2016 Aug 16;4:44
pubmed: 27532019
BMC Health Serv Res. 2010 Oct 08;10:283
pubmed: 20932288
Eur J Cancer. 2005 Jul;41(11):1533-41
pubmed: 15953716
Arch Dermatol. 1992 Jun;128(6):818-21
pubmed: 1599271
J Am Acad Dermatol. 2018 Mar;78(3):433-442
pubmed: 29229574
Clin Nucl Med. 2018 May;43(5):e142-e144
pubmed: 29538029
Eur J Radiol. 2010 Feb;73(2):317-23
pubmed: 19108971
Cancer. 2007 Oct 15;110(8):1738-44
pubmed: 17786947
J Nucl Med. 2015 Sep;56(9):1328-33
pubmed: 26159592
Nucl Med Rev Cent East Eur. 2005;8(2):135-6
pubmed: 16437401
Int J Clin Exp Med. 2012;5(4):363-6
pubmed: 23293710
J Am Acad Dermatol. 2010 Jan;62(1):76-84
pubmed: 20082888